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A B S T R A C T   
Background: Neonatal arterial ischemic stroke (NAIS) carries the risk of significant long-term neuro-
developmental burden on survivors. 
Aims: To assess the long-term neurodevelopmental outcome of term neonates diagnosed with NAIS and inves-
tigate the associations among brain territorial involvement on MRI, clinical risk factors and neurodevelopmental 
outcomes. 
Study design: Population-based cohort study. 
Subjects: Seventy-nine term neonates with NAIS confirmed by MRI born between 2007 and 2017. 
Outcome measures: Long-term neurodevelopmental outcome assessed using the Bayley Scales of Infant 
Development-II, the Brunet-Lézine test and the Binet Intelligence scales-V. 
Results: Follow-up was available in 70 (89%) of the subjects enrolled, at a median age of 60 months [IQR: 35–84]. 
Normal neurodevelopmental outcome was found in 43% of the patients. In a multivariable model, infants with 
main MCA stroke had an increased risk for overall adverse outcome (OR: 9.1, 95% CI: 1.7–48.0) and a partic-
ularly high risk for cerebral palsy (OR: 55.9, 95% CI: 7.8–399.2). The involvement of the corticospinal tract 
without extensive stroke also increased the risk for cerebral palsy/fine motor impairment (OR: 13.5, 95% CI: 
2.4–76.3). Multiple strokes were associated with epilepsy (OR: 9.5, 95% CI: 1.0–88.9) and behavioral problems 
(OR: 4.4, 95% CI: 1.1–17.5) and inflammation/infection was associated with cerebral palsy (OR: 9.8, 95% CI: 
1.4–66.9), cognitive impairment (OR: 9.2, 95% CI: 1.8–47.8) and epilepsy (OR: 10.3, 95% CI: 1.6–67.9). 
Conclusions: Main MCA stroke, involvement of the corticospinal tract, multiple strokes and inflammation/ 
infection were independent predictors of adverse outcome, suggesting that the interplay of stroke territorial 
involvement and clinical risk factors influence the outcome of NAIS.   
1. Introduction 
The pregnant woman and her fetus have risk factors that shift the 
balance of the fetal coagulation homeostasis toward a prothrombotic 
state [1]. The resulting unique fetal-neonatal coagulation status has 
been postulated to contribute to the development of perinatal stroke 
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presenting as perinatal ischemic stroke or perinatal hemorrhagic stroke. 
Perinatal ischemic stroke has been defined as a focal disruption of ce-
rebral blood flow that occurs between 20 weeks of gestation and 28 days 
after delivery and carries the risk of chronic neurological sequelae [1]. 
Based on the type of the vessel affected, the two major forms of perinatal 
ischemic stroke are arterial ischemic stroke and cerebral sinovenous 
thrombosis. Based on the time of presentation, arterial ischemic stroke 
with acute presentation during the first 28 postnatal days has been 
classified as neonatal arterial ischemic stroke (NAIS) while stroke with 
delayed presentation is identified as presumed perinatal arterial 
ischemic stroke [1–3]. The latter is usually diagnosed by imaging studies 
performed after the first postnatal month with findings suggestive of a 
stroke of perinatal origin [1]. 
In neonatal arterial ischemic stroke (NAIS), cerebral vessels are most 
commonly occluded by thrombosis or embolism [4]. The estimated 
incidence of NAIS is one in 2300 to 5000 live birth [5–7]. Therefore, 
stroke is 17 times more common in the perinatal period than any time 
later in childhood [8]. 
Neonatal arterial ischemic stroke is an important cause of long- 
lasting neurodevelopmental sequelae including hemiparetic cerebral 
palsy (CP) [9,10], cognitive [11] and language impairment [12], epi-
lepsy [13], and/or behavioral disorders often manifesting only at school 
age [14]. 
Long-term follow-up studies of NAIS patients are limited and 
population-based, longitudinal studies are lacking. Therefore, we 
designed a population-based cohort study, involving all patients born 
over an 11-year period in Central-Hungary. Our aim was to investigate 
the long-term neurodevelopmental outcomes of all patients diagnosed 
with NAIS and to describe the possible associations among clinical 
presentation, potential clinical risk factors, magnetic resonance imaging 
(MRI) findings and long-term neurodevelopmental outcome. 
2. Patients and methods 
2.1. Population 
This is a population-based cohort study designed to capture all term 
neonates with NAIS born between January 1, 2007 and December 31, 
2017 and cared for in the Central-Hungarian region, including the 
capital, Budapest. MRI scans were performed at a single center, in the 
Department of Neuroradiology, Medical Imaging Center, Semmelweis 
University, Budapest, Hungary. We reviewed the imaging studies of 
1400 term neonates (≥37 weeks) who had a head MRI performed prior 
to 28 days of life and identified 102 subjects with evidence of a focal 
cerebral arterial ischemic event. Patient selection is shown in Fig. 1. 
Inclusion criteria were: (1) term neonates up to 28 days of age (2) and a 
brain MRI confirming the diagnosis of NAIS without any other concur-
rent abnormality. We included neonates with congenital heart disease 
with the exception of those with single ventricle physiology, since 
congenital heart disease is a major risk factor for stroke [5]. We excluded 
neonates with kernicterus, encephalitis, border-zone injury or periven-
tricular leukomalacia on MRI, birth asphyxia, tumor, non-accidental 
brain injury, mitochondrial disorders and congenital syndromes with 
known adverse outcome [4]. We obtained Institutional Review Board 
Neonates with a brain MRI performed 
for neurological symptoms prior to 28 
days of age (n=1400)
Neonates with a focal cerebral arterial 
ischemic event on MRI (n=102)
Term neonates with neonatal arterial 
ischemic stroke (NAIS) selected for 
neurodevelopmental follow-up (n=79)
Live births between January 1, 2007 and 
December 31, 2017 in the Central-
Hungarian region (n=314410)
Exclusion criteria
Prematurity (<37 weeks of gestation) (n=3)
Concomitant hemorrhagic stroke and/or 
cerebral sinovenous thrombosis (n=13)
Birth asphyxia and/or periventricular 
leukomalacia (n=5)
Infants with congenital syndromes with 
known adverse outcome (spinal muscular 










Died in the 
neonatal 
period (n=2)
Fig. 1. Process of patient selection, inclusion and exclusion.  
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approval from the Hungarian Medical Research Council (19934–4/ 
2018/EKU). Informed verbal parental consent was obtained to recruit 
patients into the study and to perform neurodevelopmental assessments. 
2.2. MRI 
Brain imaging was carried out on 3 T Philips Achieva and 3 T Philips 
Ingenia MR scanners (Philips Medical Systems, Best, The Netherlands) at 
the Department of Neuroradiology, Medical Imaging Center, Semmel-
weis University, Budapest, Hungary. The scanning protocol included 
diffusion-weighted imaging, apparent diffusion coefficient map, con-
ventional T1- and T2-weighted imaging, between 2007 and 2009 T2*- 
and between 2009 and 2017 susceptibility-weighted imaging. In 
selected cases, MR angiography and/or MR spectroscopy were added, as 
appropriate. Radiologists trained and experienced in neonatal brain MRI 
evaluated the MRI scans. Classification was based on the shape, extent 
and localization of the affected brain compartment supplied by the given 
arteries [4,15]. Each stroke was assigned to one of the most predominant 
arterial territory (for further details see the Supplemental Methodology 
Statement 1, Figure Supplementary Fig. 1 [16]). The involvement of 
more than one branch of the middle cerebral artery (MCA) was desig-
nated as multiple lesions. Previous reports have described an association 
between involvement of the corticospinal tract (CST) and adverse neu-
rodevelopmental outcome including CP [17–19]. Therefore, we also 
investigated the involvement of the CST seen as “pre-Wallerian degen-
eration” on diffusion-weighted imaging at the level of the posterior limb 
of the internal capsule (PLIC) and cerebral peduncles. Strokes of <3 mm 
in size at the largest diameter were not included in this study. 
2.3. Clinical data 
Clinical information was collected from chart reviews. Gestational 
age, birthweight, sex, modes of delivery, Apgar scores, seizures, hypo-
glycemia (defined as blood glucose level < 2.6 mmol/L), need for 
resuscitation and/or mechanical ventilation and/or cardiovascular 
support, abnormal muscle tone and level of consciousness (irritability/ 
lethargy) along with other neonatal neurological symptoms were 
recorded. Specific or non-specific inflammation was defined as positive 
blood and/or cerebrospinal fluid culture or clinical signs of inflamma-
tion along with a CRP of >10 mg/L, respectively. Established risk factors 
for NAIS during pregnancy, such as gestational diabetes, preeclampsia 
and placental abruption, were collected retrospectively. We performed 
electroencephalogram (EEG) studies on 64 patients based on the clinical 
findings. The EEG signals were classified as seizure, abnormal back-
ground activity (including low voltage, flat trace, burst suppression, 
trace alternant, asynchrony or asymmetry) or normal EEG [20]. Echo-
cardiography was used as indicated to confirm/rule out congenital heart 
disease. 
2.4. Neurodevelopmental outcome 
In all patients, neurodevelopmental outcome was assessed during 
follow-up visits between the age of 1.5 to 10 years. For the purposes of 
this study, we also prospectively performed a systematic neuro-
developmental follow-up assessment of children that were diagnosed 
with NAIS and were available for follow-up in 2018. Normal outcome 
was defined as symptom free survival. Adverse outcome was noted if any 
one or more of the following sequelae occurred: CP, fine motor 
impairment, cognitive impairment, behavioral problems, epilepsy, lan-
guage delay, visual field defect or hearing loss. The developmental tests 
used during the follow-up visits and the diagnostic criteria for CP and 
epileptic syndromes are described in the Supplemental Methodology 
Statement 2 in detail [21–26]. 
2.5. Statistical analysis 
Descriptive statistics were expressed as frequencies and percentages, 
mean and standard deviation (SD) or median and interquartile range 
[IQR], as appropriate. Stroke subtypes and EEG findings were compared 
with clinical symptoms and outcome parameters by using Fisher's exact 
tests. Univariate logistic regression model was used to describe re-
lationships between clinical predictors of interest and neuro-
developmental outcome. Multivariable logistic regression model was 
applied to ascertain the effect of significant predictors including infec-
tion/inflammation, main MCA stroke and multiple strokes based on the 
notion that a patient would likely have an adverse outcome, while 
controlling for other clinically relevant factors based on the results of the 
univariate analysis and a priori knowledge. Finally, univariate and 
multivariable regression analyses were repeated after excluding patients 
with main branch MCA infarction to better determine the risk for 
adverse outcome of neonates with CST injury without extensive stroke. 
Odds ratios (OR) with 95% confidence intervals (CI) were calculated for 
each clinical variable. Two-sided statistical tests with p values of <0.05 
were considered significant. Statistical analyses were performed using 
IBM SPSS Statistics (Version 25, IBM Corp. Armonk, NY, USA). 
3. Results 
3.1. Patient characteristics and general findings 
A total of 79 neonates diagnosed with acute NAIS were identified in 
Central Hungary over the 11-year study period, yielding a disease 
incidence of 1 per 3800 live births. Clinical characteristics, maternal and 
neonatal risk factors and presenting symptoms of the study population 
are summarized in Table 1. 
The most common presenting symptom of NAIS was seizure activity, 
occurring in 75% of patients, at a median age of 2 days [IQR 1–3]. As 
expected, seizures were of focal onset in the majority of patients. The 
rate of hypoglycemia was also high, detected in 25% of the patients. 
Table 1 
Clinical characteristics, maternal and neonatal risk factors and presenting 
symptoms of neonatal arterial ischemic stroke in the study population. Fre-
quencies and percentages, mean and standard deviation (SD) or median and 
interquartile range [IQR] were calculated, as appropriate.  
Clinical characteristics, risk factors and presenting 
symptoms 
Patients with NAIS n 
= 79 
Gestational age [weeks], mean (SD) 38.8 (1.4) 
Birthweight [g], mean (SD) 3312 (592) 
Male, n (%) 50 (58) 
Apgar score 1 min, mean (SD) 7 (3) 
Apgar score 5 min, mean (SD) 9 (2) 
Gestational diabetes, n (%) 8 (11) 
Preeclampsia, n (%) 13 (16) 
Placental abruption, n (%) 17 (22) 
C-section, n (%) 42 (53) 
5-min Apgar score < 7, n(%) 9 (11) 
Congenital heart disease, n (%) 12 (15) 
Cranial arteriopathy, n (%) 9 (11) 
Infection/Inflammation, n (%) 15 (19) 
Blood stream infection 4 
Meningitis 2 
Suspected infection with CRP > 10 mg/L 9 
CRP in patients with infection/ inflammation, median [IQR] 36 [13.5–85.5] 
Clinical seizure, n (%) 59 (75) 
Postnatal day at first seizure, median [IQR] 2 [1–3] 
Hypoglycemiaa, n (%) 20 (25) 
Irritability/lethargy, n (%) 10 (13) 
Muscle tone abnormalities, n (%) 13 (16) 
Respiratory distress, n (%) 29 (37) 
Need for complex resuscitation and/or mechanical 
ventilation and/or cardiovascular support, n (%) 
7 (9)  
a Hypoglycemia was defined as blood glucose level < 2.6 mmol/L. 
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3.2. Affected brain regions 
Diagnostic brain MRI was performed at a median age of 5 [IQR 3–7] 
days. The most commonly affected brain regions were the areas supplied 
by the main (n = 16, 20%), the anterior (n = 17, 22%) and the posterior 
branches of the MCA (n = 15, 19%). Stroke was more often left sided (n 
= 38, 48%) and, similarly to findings in the literature multiple strokes (n 
= 33, 42%) were common. Involvement of the CST was described in 28 
neonates (35%). Detailed frequencies of stroke subtypes are shown in 
Table 2. 
Analysis of associations between clinical characteristics and stroke 
subtypes revealed that hypoglycemia was more often found in PCA 
strokes compared with the other subtypes (56% vs. 21%, p = 0.04). 
Muscle tone abnormalities were noted more frequently in strokes of the 
perforator arteries (43% vs. 8%, p = 0.005). Neonates with infection/ 
inflammation did not have significantly higher rate of cerebral arterio-
pathy compared to neonates without evidence of infection/inflamma-
tion (20% vs. 9%, p = 0.5). In addition, patients with infection/ 
inflammation did also not have more areas of infarct or higher rates of 
main branch MCA stroke than the other subgroups (54% vs. 44%, p =
0.5 and 31% vs. 19%, p = 0.5, respectively). 
3.3. Neurodevelopmental outcome 
Long-term neurodevelopmental outcome data were available in 70 
(89%) of the 79 patients with the last follow-up visit occurring at a 
median age of 60 [IQR 35–84] months. Of the 9 patients not included in 
the analysis, two died from complications of stroke and congenital heart 
disease in the neonatal period, three had follow-up examinations be-
tween 12 and 18 months of age with normal neurodevelopment but were 
lost to follow-up thereafter; and four were lost to follow-up after the 
neonatal period. All infants lost to follow-up had small, 5–7 mm stroke 
territorial involvement on MRI not involving the basal ganglia and 
thalami. 
Thirty of the 70 patients (43%) with longitudinal follow-up had 
normal neurodevelopmental outcome. Among the subjects with adverse 
neurodevelopmental outcomes, CP was the most frequent finding, 
documented in 20 patients (29% of all patients with follow-up). Thus, 
among the 40 subjects with adverse neurodevelopmental outcomes, 
50% were diagnosed with CP. Of them, 17 children (85% of patients 
with CP) had unilateral hemiparesis and the remaining three children 
(15% of patients with CP) presented with tetraparesis. In addition to CP, 
fine motor impairment (13%), as well as cognitive deficit (17%), 
behavioral problems (21%, two-thirds of whom had attention deficit 
hyperactivity disorder) and speech delay (23%) were common. Active 
epilepsy was documented at the time of assessment in 7 patients (10%). 
Hearing loss and visual field defects were rare (4% and 3%, 
respectively). 
To further assess the co-occurrence of the adverse outcome variables, 
we created three main categories and plotted patients on a Venn dia-
gram: (1) CP and/or fine motor impairment, (2) cognitive impairment 
and/or behavioral problems, (3) language delay and/or visual field 
defects and/or hearing loss and we also included patients with epilepsy 
(Fig. 2). Even though more than one type of adverse neuro-
developmental outcome was recorded in 18 subjects (26%), the co- 
occurrence of adverse outcome measures in the three major domains 
(motor skills, cognitive field and sensory/language field) was relatively 
low (n = 8, 11%). The rate of severe CP was low (n = 3, 4%) and 
moderate-to-severe global intellectual deficit was also relatively rare (n 
= 7, 10%). 
Interestingly, we detected an association between cognitive impair-
ment and epilepsy (p = 0.04) and language delay (p = 0.004). Moreover, 
we also found associations between behavioral problems and cognitive 
impairment (p = 0.016) and language delay (p = 0.003). Finally, CP was 
Table 2 
MRI findings of territorial involvement and specific arteries affected by NAIS and adverse outcome domains per stroke territory subtypes. Frequencies of specific 
neurological outcome domains per stroke territory subtypes were calculated in infants with long-term follow-up.  
NAIS types and 
outcomes 
Total n 




















hearing problems n 







n = 40, (n%) 
Arterial involvement 
Main MCA 16 (20) 15 (21) 13 
(87) 
3 (20) 6 (40) 7 (47) 9 (60) 5 (33) 14 (93) 
Anterior MCA 17 (22) 16 (23) 3 
(19) 
1 (6) 2 (13) 0 (0) 3 (19) 1 (6) 8 (50) 
Middle MCA 11 (14) 11 (16) 1 (9) 0 (0) 1 (9) 1 (9) 2 (18) 0 (0) 4 (36) 
Posterior MCA 15 (19) 12 (17) 1 (8) 2 (17) 0 (0) 6 (50) 2 (17) 1 (13) 8 (67) 
Perforator stroke 9 (11) 7 (10) 
1 
(14) 
0 (0) 1 (14) 0 (0) 1 (14) 1 (8) 3 (43) 
PCA/ACA 12 (15) 9 (13) 1 
(11) 
3 (33) 2 (22) 1 (11) 1 (11) 1 (11) 4 (44) 
Multiple strokes 33 (42) 32 (46) 
13 
(41) 5 (16) 7 (22) 11 (34) 11 (34) 7 (22) 23 (72)  
Territorial involvement 
PLIC +/− cerebral 
peduncles 28 (35) 27 (39) 
17 
(63) 6 (22) 8 (30) 9 (33) 13 (48) 6 (22) 24 (89) 
PLIC +/− cerebral 
peduncles without 
main branch MCAa 
12 (15) 12 (17) 
4 
(33) 3 (25) 2 (17) 2 (17) 4 (33) 1 (8) 10 (83)  
Side of stroke lesion 
Right stroke 23 (29) 20 (29) 6 
(30) 
3 (15) 6 (30) 6 (30) 6 (30) 4 (20) 9 (45) 
Left stroke 38 (48) 35 (50) 
9 
(26) 5 (14) 2 (6) 3 (9) 5 (14) 3 (9) 20 (57) 
Bilateral strokes 18 (23) 15 (21) 
5 
(33) 
1 (7) 4 (27) 6 (40) 7 (47) 2 (13) 11 (73) 
Percentages are shown in brackets. 
Abbreviations: MCA: middle cerebral artery, PCA: posterior cerebral artery, ACA: anterior cerebral artery, PLIC: posterior limb of internal capsule, CP: cerebral palsy. 
a Frequencies calculated in patients after excluding those with main branch MCA stroke. 
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Fig. 2. Venn diagram of all infants with NAIS and 
long-term follow-up results (n = 70). Neuro-
developmental outcome was assessed after 18 months 
of age in all patients. Female and male symbols 
represent single patients. Patients are categorized as 
follows: yellow circle: cerebral palsy and/or fine motor 
impairment; blue circle: cognitive impairment and/or 
behavioral problems; green circle: language delay 
and/or visual field defects and/or hearing loss. 
Symbols in red indicate patients with active epilepsy, 
symbols with an asterix indicate patients who are 
seizure-free for more than 1 year without treatment. 
(For interpretation of the references to colour in this 
figure legend, the reader is referred to the web 
version of this article.)   
Table 3 
Results of multivariable logistic regression analysis represented by adjusted odds ratios and 95% confidence intervals predicting the likelihood of adverse outcomes in 
patients with NAIS and main branch MCA stroke and/or inflammation/infection (A) and predicting the likelihood of adverse outcomes in patients with NAIS and 
multiple strokes (B).  
A  








Infection/Inflammation, aOR [95% 
CI] 
9.8 [1.4–66.9] 9.2 [1.8–47.8] NS 10.3 [1.6–67.9] NS NS 
Main MCA, aOR [95% CI] 
55.9 
[7.8–399.2] 6.4 [1.2–33.3] 8.8 [1.9–41.4] 
17.3 
[2.0–153.5] 9.7 [2.3–41.4] 9.1 [1.7–48.0] 
Hypoglycemia, aOR [95% CI] NS NS NS NS NS NS 
Seizure, aOR [95% CI] NS NS NS NS NS NS 
Need for resuscitation, aOR [95% 
CI] 
NS NS NS NS NS NS   
B  
Cerebral palsy Behavioral problems Epilepsy Adverse outcome 
Infection/inflammation, aOR [95% CI] 4.9 [1.1–21.6] NS 10.6 [1.7–67.9] NS 
Multiple strokes, aOR [95% CI] NS 4.4 [1.1–17.5] 9.5 [1.0–88.9] 3.2 [1.1–9.2] 
Hypoglycemia, aOR [95% CI] NS NS NS NS 
Seizure, aOR [95% CI] NS NS NS NS 
Need for resuscitation, aOR [95% CI] NS NS NS NS 
Abbreviations: CI: confidence interval, aOR: adjusted odds ratio, NS: non-significant. 
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associated with epilepsy, language delay and cognitive impairment (p =
0.01, p < 0.001 and p = 0.002, respectively). 
3.4. Risk factors associated with adverse neurodevelopmental outcome 
Univariate analysis of stroke territory subtypes and their relation to 
neurodevelopmental outcome domains revealed several associations 
between MRI parameters and neurodevelopmental outcome domains 
(Supplemental Table 1A). Main MCA stroke, multiple strokes and the 
involvement of the CST were associated with increased odds for overall 
adverse outcomes. Indeed, 93% of patients with main branch MCA 
stroke had neurological impairment, compared to 29% to 67% of other 
NAIS subtypes and the rate of CP was especially high (87%). After 
excluding neonates with main branch MCA stroke, patients with CST 
involvement still had a high rate of adverse neurodevelopmental 
outcome (83%) compared to those without CST involvement (37%). 
Among the clinical risk factors, evidence for infection/inflammation 
conferred significantly higher odds for adverse outcome in several 
developmental domains (Supplemental Table 1B). 
Multivariable logistic regression analysis revealed that the presence 
of main MCA stroke and signs of infection/inflammation were signifi-
cant independent predictors of impairment in several neuro-
developmental domains (Table 3A). Infants with main MCA stroke had 
9.1 times higher odds (95% CI: 1.7–48.0) for overall adverse outcome, 
and main branch MCA infarction was associated with CP, cognitive and 
behavioral problems, epilepsy and visual/hearing/language problems. 
Interestingly, infection/inflammation was associated with adverse 
outcome only in certain neurodevelopmental domains, including a 
higher likelihood for CP, cognitive deficit and epilepsy. As main MCA 
stroke and multiple strokes showed collinearity (R = 0.6, p < 0.05), we 
repeated the multivariable analysis with the same independent variables 
except for replacing main branch MCA stroke with multiple strokes and 
found multiple strokes to be significantly associated with epilepsy (OR: 
9.5; 95% CI: 1.0–88.9) and behavioral problems (OR: 4.4; 95% CI: 
1.1–17.5) (Table 3B). Finally, after excluding patients with main branch 
MCA stroke, the involvement of PLIC with or without cerebral peduncles 
was associated with an increased risk for overall adverse outcome (OR: 
6.5; 95% CI: 1.1–36.6) and CP/fine motor impairment (OR: 13.5; 95% 
CI: 2.4–76.3) (Table 4). 
Of the patients who had EEG studies done on admission (n = 64, 
81%) and were available for long-term follow-up (n = 58, 73%), normal 
EEG was recorded in 26 of the 58 patients (45%), seizure activity was 
detected in 19 (33%) infants and abnormal background activity was 
recognized in 17 (29%) subjects. Interestingly, neonates with seizure 
activity on EEG developed later epilepsy more frequently compared to 
those without seizure activity on EEG (26.3% vs. 8.3%, p = 0.05). 
Additionally, patients with abnormal background activity on EEG had 
adverse neurodevelopmental outcome more often compared to those 
without abnormal background activity on EEG (70.6% vs. 48.8%, p =
0.05). 
4. Discussion 
This is a population-based cohort study of term neonates with NAIS 
born over an 11-year period in Central-Hungary. The main importance 
of this study is that a high proportion of infants had follow-up, per-
formed between 18 months of age up to early school age, allowing for 
detailed documentation of the status of long-term neurodevelopmental 
outcome data. Longitudinal examination of neurological sequelae in 
patients with perinatal brain injury is particularly important because 
speech and other higher cognitive functions emerge later in childhood 
[27]. Importantly, in our study, almost half of the patients (43%) had 
normal outcome likely reflecting, among others, the potential of the 
developing brain for reorganization. Nevertheless, we have also 
demonstrated that main MCA stroke, multiple strokes, the involvement 
of the CST and infection/inflammation were independent predictors of 
adverse outcome. 
In addition to allowing for the prompt diagnosis of NAIS, brain MRI 
scans also aid the clinician in the prognostication of long-term outcome 
based on stroke territory subtypes [15,28]. It has been generally 
accepted that the ability of early prognostication and parental coun-
seling are of clinical relevance in patients with NAIS as early interven-
tion strategies may aid in optimizing motor and mental development 
[29]. In agreement with previous observations [15], we have also found 
that the volume of territorial involvement is important in predicting 
adverse outcome [30,31] as seen in the cases of main branch MCA stroke 
and multiple strokes. Of note is that main branch MCA stroke was not 
only associated with neurological impairment in most of the affected 
patients (93%) but the rate of CP was especially high (87%) compared to 
patients with other stroke subtypes (8–19%). Nevertheless, all of these 
neonates had a large stroke with the involvement of the CST, the basal 
ganglia, the thalamus and the cerebral cortex. Therefore, we cannot 
conclude whether the large territorial involvement in itself, the 
involvement of certain specific anatomic regions or both are responsible 
for the development of CP/adverse outcome in these patients. 
Involvement of the CST has been associated with poor outcome in 
general and CP in particular [15,17,18]. Interestingly, other studies 
have shown that the concomitant involvement of the cortical and 
subcortical structures, particularly the PLIC, the basal ganglia and the 
cerebral cortex predicted hemiplegia [10]. Therefore, to better investi-
gate the role of CST involvement in the long-term outcome of NAIS, after 
excluding infants with main branch MCA stroke, we assessed the impact 
of injury of the CST at the level of PLIC with or without the involvement 
of cerebral peduncles. While controlling for other important clinical 
variables, involvement of the CST increased the overall risk for adverse 
outcome and CP/fine motor impairment. Nevertheless, 40% of the pa-
tients with CST involvement without a widespread stroke did not have 
motor deficit in the long-run and 25% of them only had fine motor 
impairment. These findings might be explained by the neuroplasticity of 
the developing brain following perinatal brain injury. 
Studies have reported the rate of epilepsy to be in the 10–54% range 
in cases with NAIS [32–35] and we have found that the overall rate of 
epilepsy was 13% in our cohort. Our findings also indicate that the risk 
of developing epilepsy is higher with main branch MCA or multiple 
strokes and when there is clinical evidence of inflammation/infection. 
These findings support previous observations that the risk of developing 
epilepsy is higher when multiple vessels are involved or when more 
substantial tissue damage occurs [34]. Additionally, our observations 
that epilepsy co-occurred with other neurodevelopmental sequelae such 
as cognitive impairment and CP suggest that certain neuro-
developmental outcomes might share a common origin [15,36] and that 
epilepsy might limit plasticity of the brain during development [37,38]. 
Although infection has been recognized as a risk factor for neonatal 
or childhood stroke [39], to the best of our knowledge, this is the first 
Table 4 
Results of multivariable logistic regression analysis represented by adjusted odds 
ratios and 95% confidence intervals predicting the likelihood of overall adverse 
outcome and cerebral palsy/fine motor involvement in patients after excluding 







PLIC +/− cerebral 
peduncles 
NS 13.5 [2.4–76.3] 6.5 
[1.1–36.6] 
Infection/inflammation, 






NS NS NS 
Seizure, aOR [95% CI] NS NS NS 
Need for resuscitation, 
aOR [95% CI] 
NS NS NS 
Abbreviations: PLIC: posterior limb of internal capsule, CI: confidence interval, 
aOR: adjusted odds ratio, NS: non-significant. 
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study that reports the presence of specific or non-specific inflammation 
as an independent predictor for adverse neurodevelopmental outcome, 
in particular CP, cognitive impairment and epilepsy in patients with 
NAIS. We speculate that the inflammation-associated release of cyto-
kines, chemokines and other local factors might lead to the development 
of selective intracranial arteritis [40], increase the severity of the stroke 
[5] and/or affect brain development in the postnatal period. 
There is no clear evidence whether arterial stenosis or vessel irreg-
ularity contributes to the development of cerebral infarction [41] or 
alternative mechanisms such as vasospasm [42] play a role in the 
development of NAIS in the presence of signs of infection. In our study, 
rates of cerebral arteriopathy were similar in neonates with and without 
evidence for inflammation/infection. While neonates with large areas of 
infarct/multiple strokes are at higher risk for poor outcome [30,34,43], 
in the present study, neonates with infection/inflammation did not have 
increased areas of infarct compared to those without infection/inflam-
mation. Therefore, the unfavorable outcome in this subgroup of patients 
might not be attributed to the size of the stroke. As elevated CRP with or 
without culture positivity was an independent predictor of poor long- 
term neurodevelopmental outcome, it is tempting to speculate that pa-
tients, who respond to the tissue damage with enhanced inflammation, 
with or without an identifiable infectious source, might be at risk for 
more substantial tissue damage [44]. Clearly, further prospective studies 
are needed to delineate the association between NAIS and inflammation 
and adverse outcomes. Yet, it is reasonable to suggest exercising caution 
when inflammatory reaction is detected in this patient population dur-
ing the acute phase of the disease process and initiating appropriate 
early interventions and a thorough follow-up in this patient population. 
Finally, in line with previous findings [34,45], we have found that 
severe disability and the co-occurrence of impairment in all neurological 
domains were rare. Moreover, 43% of the patients had normal long-term 
neurodevelopmental outcome. As approximately 30–60% of patients 
with NAIS develop CP, current treatment has primarily focused on 
improving motor outcomes. Indeed, constraint induced movement 
therapy and transcranial magnetic stimulation have been shown to 
improve motor outcome [46]. Since central nervous system plasticity is 
likely the maximal in the neonatal period and during early infancy [47], 
early initiation of developmental support, environmental enrichment 
and parental advocacy are thought to be of great importance in 
ameliorating brain injury and enhancing the chances of white matter 
recovery [48]. 
Our study also has limitations to be considered. Firstly, the analysis 
conducted utilized in part retrospectively collected data and was per-
formed on data obtained over a relatively long period of time, with its 
inherent disadvantages. Secondly, due to the uncommon diagnosis of 
NAIS, we collected data from all Neonatal Intensive Care Units in Cen-
tral Hungary with somewhat diverse clinical management styles. 
Nevertheless, the relatively high level of harmonization by the universal 
health care system in Hungary might have attenuated some of the 
consequences of the multicenter nature of the data collection. Finally, 
some subgroups of important anatomical lesions were too small to draw 
statistical conclusions. As NAIS is a rare condition, thoroughly 
controlled data collection by regional or national registries utilizing an 
appropriate oversight structure remain the main avenues for statistically 
robust data collection, hypothesis generation and testing for treatment 
and determining outcome of neonates with this condition. 
5. Conclusions 
We found that close to half of the patients with NAIS had normal 
neurodevelopmental outcome. On the other hand, main MCA stroke, 
multiple strokes, the involvement of the CST and infection/inflamma-
tion were all independent predictors of adverse outcome, suggesting that 
the interplay between stroke territorial involvement and clinical risk 
factors might influence the evolution of the disease and long-term brain 
developmental processes. 
Supplementary data to this article can be found online at https://doi. 
org/10.1016/j.earlhumdev.2021.105393. 
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from symptoms to follow-up, Ideggyogy Sz. 71 (3–4) (2018) 127–136. 
[17] A. Biswas, K. Mankad, M. Shroff, P. Hanagandi, P. Krishnan, Neuroimaging 
perspectives of perinatal arterial ischemic stroke, Pediatr. Neurol. 113 (2020) 
56–65. 
[18] B. Husson, L. Hertz-Pannier, C. Renaud, D. Allard, E. Presles, P. Landrieu, et al., 
Motor outcomes after neonatal arterial ischemic stroke related to early MRI data in 
a prospective study, Pediatrics. 126 (4) (2010) 912–918. 
[19] M. Dinomais, L. Hertz-Pannier, S. Groeschel, S. Chabrier, M. Delion, B. Husson, et 
al., Long term motor function after neonatal stroke: lesion localization above all, 
Hum. Brain Mapp. 36 (12) (2015) 4793–4807. 
[20] M.S. Scher, Electroencephalography of the newborn : Normal and abnormal 
features, in: Niedermeyer E, Lopes da Silva FH, Eds Electroencephalography, 5th 
ed, Lippincott Williams and Wilkins, Philadelphia, 2005, pp. 937–990. 
[21] N. Bayley, BSID-II: Bayley Scales of Infant Development, Second edition, Hartcourt 
Brace & Company, San Antonio, 1993. 
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